Literature DB >> 7689802

Resolution of severe pyoderma gangrenosum in a patient with streaking leukocyte factor disease after treatment with tacrolimus (FK 506).

K Abu-Elmagd1, D H Van Thiel, B V Jegasothy, J C Jacobs, P Carroll, H Rodriquez-Rilo, C D Ackerman, J J Fung, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7689802      PMCID： PMC3091479          DOI： 10.7326/0003-4819-119-7_part_1-199310010-00008

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  14 in total

1.  "Streaking leukocyte factor," arthritis, and pyoderma gangrenosum.

Authors:  J C Jacobs; E J Goetzl
Journal:  Pediatrics       Date:  1975-10       Impact factor: 7.124

2.  Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum.

Authors:  K Abu-Elmagd; B V Jegasothy; C D Ackerman; A W Thomson; H Rilo; N Nikolaidis; D Van Thiel; J J Fung; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

Review 3.  Adverse effects associated with the use of FK 506.

Authors:  J J Fung; M Alessiani; K Abu-Elmagd; S Todo; R Shapiro; A Tzakis; D Van Thiel; J Armitage; A Jain; J McCauley
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

4.  Pyoderma gangrenosum in infancy: the youngest reported patient.

Authors:  A T Glass; E Bancila; S Milgraum
Journal:  J Am Acad Dermatol       Date:  1991-07       Impact factor: 11.527

5.  FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.

Authors:  T Kino; H Hatanaka; S Miyata; N Inamura; M Nishiyama; T Yajima; T Goto; M Okuhara; M Kohsaka; H Aoki
Journal:  J Antibiot (Tokyo)       Date:  1987-09       Impact factor: 2.649

6.  FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics.

Authors:  T Kino; H Hatanaka; M Hashimoto; M Nishiyama; T Goto; M Okuhara; M Kohsaka; H Aoki; H Imanaka
Journal:  J Antibiot (Tokyo)       Date:  1987-09       Impact factor: 2.649

7.  A highly sensitive method to assay FK-506 levels in plasma.

Authors:  K Tamura; M Kobayashi; K Hashimoto; K Kojima; K Nagase; K Iwasaki; T Kaizu; H Tanaka; M Niwa
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

8.  Leukokinesis-enhancing factor in human serum: partial characterization and relationship to disorders of leukocyte migration.

Authors:  E G Maderazo; C L Woronick; P A Ward
Journal:  Clin Immunol Immunopathol       Date:  1979-04

9.  Effects of tetracycline on leukotaxis.

Authors:  R R Martin; G A Warr; R B Couch; H Yeager; V Knight
Journal:  J Infect Dis       Date:  1974-02       Impact factor: 5.226

10.  The chemosuppression of chemotaxis.

Authors:  P A Ward
Journal:  J Exp Med       Date:  1966-08-01       Impact factor: 14.307
View more
  4 in total

1.  Brief report: genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne).

Authors:  Andrew P Demidowich; Alexandra F Freeman; Douglas B Kuhns; Ivona Aksentijevich; John I Gallin; Maria L Turner; Daniel L Kastner; Steven M Holland
Journal:  Arthritis Rheum       Date:  2011-12-12

2.  [Management of pyoderma gangrenosum. An update on clinical features, diagnosis and therapy].

Authors:  L Trémezaygues; R Schmaltz; T Vogt; J Reichrath
Journal:  Hautarzt       Date:  2010-04       Impact factor: 0.751

3.  Pyoderma gangrenosum: From historical perspectives to emerging investigations.

Authors:  Misty M Hobbs; Alex G Ortega-Loayza
Journal:  Int Wound J       Date:  2020-05-06       Impact factor: 3.315

4.  Clinical and Genetic Findings of the First Report of PAPA Syndrome in Brazil.

Authors:  Sérgio Júlio Fernandes; Maria Isabel Valdomir Nadaf; Nauro Hudson Monteiro; Izabel Nazira Nadaf; Cleiton Ribeiro Lélis; Bianca Yumi Takano; Bárbarah Gabriella de Camargo Monteiro; Nyvea Gabriella de Camargo Monteiro; Olga Akiko Takano; Leonardo Oliveira Mendonça
Journal:  Case Reports Immunol       Date:  2021-12-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.